Biochem/physiol Actions
Cell permeable: no
Reversible: no
Product does not compete with ATP.
Primary TargetInosine monophosphate dehydrogenase
General description
An immunosuppressive agent that inhibits de novo purine nucleotide synthesis via inhibition of inosine monophosphate dehydrogenase and prevents the formation of XMP and GMP. Useful for selection of animal cells that express the E. coli gene coding for xanthine-guanine phosphoribosyltransferase. Also suppresses cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells.
An immunosuppressive agent that inhibits de novo purine nucleotide synthesis via inhibition of IMP dehydrogenase and prevents the formation of XMP and GMP. Useful for selection of animal cells that express the E. coli gene coding for xanthine-guanine phosphoribosyltransferase. Also suppresses cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Langman, L.J., et al. 1995. Clin. Chem. 41, 295.Senda, M., et al. 1995. Transplantation60, 1143.Warner-Bartnicki, A.L., et al. 1993. Exp. Cell Res.204, 241.Falkner, F.G., and Moss, B. 1988. J. Virol.62, 1849.Cohen, M.B., et al. 1981. J. Biol. Chem.256, 8713.Mulligan, R.C., and Berg, P. 1981. Proc. Natl. Acad. Sci. USA78, 2072.
Packaging
100, 500 mg in Plastic ampoule
Reconstitution
Following reconstitution, sterilize by filtration through a 0.22 µm pore-size filter, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
Warning
Toxicity: Harmful & Carcinogenic / Teratogenic (E)
This product has met the following criteria to qualify for the following awards: